Skip to main content
Figure 6 | BMC Cardiovascular Disorders

Figure 6

From: Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice

Figure 6

Reduced β 2 GP I down-regulated the p38MAPK signaling pathway in aortas. Aorta was sampled at day 22 (mono-dose groups) and day 43 (complex-dose groups) with ten aortas selected from each group after treatment and then assessed by real time PCR (GADPH was selected as the internal control) and Western Blotting (β-Tublin was selected as the internal control). A. Relative fold change in p38MAPK mRNA levels. B. Ratio of phosphorylated p38MAPK to p38MAPK protein. * P < 0.05 vs. normal control; # P < 0.05 vs. diabetic controls; @ P < 0.05 vs. reduced β2GP I (R-β2GP I); and &P < 0.05 vs. β2GP I.

Back to article page